Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1 Inhibitors in the Treatment of Cancer: An Overview of Systematic ReviewsShunlong Ou, Qian Jiang, Song Wang et al.|Frontiers in Immunology|2022Cited by 22
Advancing perspectives on the off-label use of anticancer drugs: an updated classification and exploration of categoriesXiaoyi Chen, Qian Jiang, Zhisan He et al.|Frontiers in Pharmacology|2024Cited by 6
Dimensions and criteria of value assessment frameworks for generic drugs: A scoping review and thematic analysisZhisan He, Xiaoli Qin, Qian Jiang et al.|Health Policy and Technology|2025Cited by 1
Dimensions and Criteria of Value Assessment Frameworks for Generic Drugs: A Scoping Review and Thematic AnalysisZhisan He, Qian Jiang, Xiaoyi Chen et al.|SSRN Electronic Journal|2024Cited by 0